| For: | Li QY, Gong T, Huang YK, Kang L, Warner CA, Xie H, Chen LM, Duan XQ. Role of noncoding RNAs in liver fibrosis. World J Gastroenterol 2023; 29(9): 1446-1459 [PMID: 36998425 DOI: 10.3748/wjg.v29.i9.1446] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v29/i9/1446.htm |
| Number | Citing Articles |
| 1 |
Kurt Sartorius, Yanglong Wang, Benn Sartorius, Samuel O. Antwi, Xiaodong Li, Anil Chuturgoon, Chongyuan Yu, Yunjie Lu, Yu Wang. The interactive role of microRNA and other non-coding RNA in hepatitis B (HBV) associated fibrogenesis. Functional & Integrative Genomics 2025; 25(1) doi: 10.1007/s10142-024-01519-4
|
| 2 |
Taicheng Zhang, Jie Jing, Yaodan Liang, Jianming Luo, Dongyu Cheng, Shanyu Qin, Haixing Jiang. Resveratrol-stimulated macrophage exosomes delivering lncRNA Snhg6 inhibit liver fibrosis by modulating the NF-κB pathway. Genomics 2025; 117(3): 111043 doi: 10.1016/j.ygeno.2025.111043
|
| 3 |
László Orosz, Károly Péter Sárvári, Áron Dernovics, András Rosztóczy, Klára Megyeri. Pathogenesis and clinical features of severe hepatitis E virus infection. World Journal of Virology 2024; 13(2): 91580 doi: 10.5501/wjv.v13.i2.91580
|
| 4 |
Margherita Sisto, Sabrina Lisi. Targeting Interleukin-17 as a Novel Treatment Option for Fibrotic Diseases. Journal of Clinical Medicine 2023; 13(1): 164 doi: 10.3390/jcm13010164
|
| 5 |
Hai-Quan Wang, Lu Zhang, Ming-Jie Li, Rong-Quan He, Di-Yuan Qin, Bin Li, Jian-Di Li, Ke-Jun Wu, Shi-De Li, Han He, Zhen-Bo Feng, Gang Chen. Tumor microenvironment: new era in exosomal circRNA research - a bibliometric analysis. Extracellular Vesicles and Circulating Nucleic Acids 2025; 6(2): 245 doi: 10.20517/evcna.2024.102
|
| 6 |
Kexin Yu, Yuanxiang Jin, Yidong Zhou, Qiaoping Xu. Long non-coding RNA in hepatocellular carcinoma: mechanistic insights and therapeutic perspectives. Cellular Oncology 2025; doi: 10.1007/s13402-025-01119-9
|
| 7 |
Hui Ling, Xian-Chen Wang, Zhi-Yan Liu, Sui Mao, Jing-Jing Yang, Ji-Ming Sha, Hui Tao. Noncoding RNA network crosstalk in organ fibrosis. Cellular Signalling 2024; 124: 111430 doi: 10.1016/j.cellsig.2024.111430
|
| 8 |
Youtian Zhang, Long Ren, Yinting Tian, Xiaohu Guo, Fengxian Wei, Yawu Zhang. Signaling pathways that activate hepatic stellate cells during liver fibrosis. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1454980
|
| 9 |
Yan Zhao, Xin-quan Wu, Shu-li Liao. Rutaecarpine alleviates liver fibrosis by modulating the TRPV1/Connexin 43 axis: A study based on transcriptome data, single-cell sequencing data, and cell experiments. Biochemical and Biophysical Research Communications 2025; 781: 152506 doi: 10.1016/j.bbrc.2025.152506
|
| 10 |
杰 董. Serum Markers for Liver Fibrosis Assessment in Patients with Chronic Hepatitis B. Advances in Clinical Medicine 2023; 13(10): 16863 doi: 10.12677/ACM.2023.13102362
|
| 11 |
Sana Raza, Rukshana Mahamood, Pratik Medhe, Ambuj Shahi, Abhishek Yadav, Archana Tewari, Rohit A. Sinha. Sterile inflammation in MASH: emerging role of extracellular RNA and therapeutic strategies. npj Metabolic Health and Disease 2025; 3(1) doi: 10.1038/s44324-025-00083-0
|
| 12 |
Auriane de Pellegars-Malhortie, Laurence Picque Lasorsa, Thibault Mazard, Fabien Granier, Corinne Prévostel. Why Is Wnt/β-Catenin Not Yet Targeted in Routine Cancer Care?. Pharmaceuticals 2024; 17(7): 949 doi: 10.3390/ph17070949
|
| 13 |
Qiumei Zhou, Xue Zhang, Sen Chen, Chang Fan, Kaiqiang Wan, Chao Wu, Xiaoli Wang, Wancun Zhang, Hui Jiang. Shugan Jianpi Formula attenuate liver fibrosis via regulation of miR-193a-3p/TGF-β2 in hepatic stellate cells: An in vivo and in vitro study. Journal of Ethnopharmacology 2025; 340: 119120 doi: 10.1016/j.jep.2024.119120
|
